hematologyandoncology.net
Supplements
http://www.hematologyandoncology.net/index.php/supplements
Sign Up for Email Updates. For Email Newsletters you can trust. Poly (ADP-Ribose) polymerase (PARP) inhibitor. Highlights in CINV From the 2016 MASCC/ISOO Annual Meeting. Progressive Differentiated Thyroid Cancer: Best Use of the Tyrosine Kinase Inhibitors. The Changing Landscape in the Frontline Treatment of Chronic Lymphocytic Leukemia. Highlights in GEP-NETs From the 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease. Highlights in GEP-NETs From the 2015 Ameri...
hematologyandoncology.net
The Potential Threat to Blood Transfusion Safety of Emerging Infectious Disease Agents
http://www.hematologyandoncology.net/index.php/archives/july-2015/the-potential-threat-to-blood-transfusion-safety-of-emerging-infectious-disease-agents
Sign Up for Email Updates. For Email Newsletters you can trust. July 6, 2015. The Potential Threat to Blood Transfusion Safety of Emerging Infectious Disease Agents. Clinical Advances in Hematology and Oncology. July 2015, Volume 13, Issue 7. Susan L. Stramer, PhD. Vice President, Scientific Affairs. How safe is the US blood supply at this time? Are there agents that we currently do not test for that pose a potential risk? We do not usually test for Babesia. Do you think that Babesia. Because this parasi...
hematologyandoncology.net
Archives
http://www.hematologyandoncology.net/index.php/archives
Sign Up for Email Updates. For Email Newsletters you can trust. Poly (ADP-Ribose) polymerase (PARP) inhibitor. Letter from the Editor: The Campaign Button. Trifluridine/Tipiracil and Regorafenib: New Weapons in the War Against Metastatic Colorectal Cancer. The Status of Poly(Adenosine Diphosphate-Ribose) Polymerase (PARP) Inhibitors in Ovarian Cancer, Part 1: Olaparib. Moving Beyond Monotherapy in the Immunotherapeutic Arena: Prospects for Combination Therapies in Lung Cancer. Prevention and Treatment of...
hematologyandoncology.net
Managing Primary Central Nervous System Lymphoma
http://www.hematologyandoncology.net/index.php/archives/july-2015/managing-primary-central-nervous-system-lymphoma
Sign Up for Email Updates. For Email Newsletters you can trust. July 7, 2015. Managing Primary Central Nervous System Lymphoma. Clinical Advances in Hematology and Oncology. July 2015, Volume 13, Issue 7. Tracy Batchelor, MD, MPH. Stephen E. and Catherine Pappas Center for Neuro-Oncology. Could you briefly describe primary central nervous system (CNS) lymphoma in immunocompetent patients? How is primary CNS lymphoma diagnosed? The next step is a biopsy, typically a stereotactic needle biopsy, performed b...
gastroenterologyandhepatology.net
Hemostatic Powder TC-325
http://www.gastroenterologyandhepatology.net/index.php/archives/july-2015/hemostatic-powder-tc-325
Sign Up for Email Updates. For Email Newsletters you can trust. July 3, 2015. Alan Barkun, MD. Douglas G. Kinnear Chair in Gastroenterology and Professor of Medicine. Director of Digestive Endoscopy (adult section). McGill University and the McGill University Health Centre. Montréal, Québec, Canada. What therapeutic options have traditionally been available for endoscopic hemostasis of gastrointestinal bleeding? What limitations are associated with these modalities? What are the main advantages and disad...
hematologyandoncology.net
Stool DNA Testing: A New, Noninvasive Option for Colorectal Cancer Screening
http://www.hematologyandoncology.net/index.php/archives/july-2015/stool-dna-testing-a-new-noninvasive-option-for-colorectal-cancer-screening
Sign Up for Email Updates. For Email Newsletters you can trust. July 4, 2015. Stool DNA Testing: A New, Noninvasive Option for Colorectal Cancer Screening. Clinical Advances in Hematology and Oncology. July 2015, Volume 13, Issue 7. David A. Ahlquist, MD. What are the limitations of the existing methods of colorectal cancer (CRC)screening? How can the noninvasive multitarget stool DNA test you helped develop make a difference? How does the stool DNA test work? Testing is performed on samples sent to a ce...
gastroenterologyandhepatology.net
About
http://www.gastroenterologyandhepatology.net/index.php/about
Sign Up for Email Updates. For Email Newsletters you can trust. Gastroenterology and Hepatology (G&H),. Is a monthly peer-reviewed journal reaching 16,300 gastroenterologists and hepatologists. Also publishes industry-supported Meeting Highlights, Clinical Roundtable Monographs, and Clinical Review Supplements. Both the journal and all affiliated supplements are included in the National Library of Medicine’s PubMed/MEDLINE index as well as EMBASE.
gastroenterologyandhepatology.net
Videos
http://www.gastroenterologyandhepatology.net/index.php/videos
Sign Up for Email Updates. For Email Newsletters you can trust. Oops, Post Not Found! Uh Oh Something is missing. Try double checking things. This is the error message in the custom posty type archive template.
gastroenterologyandhepatology.net
Defining Severity in Inflammatory Bowel Disease
http://www.gastroenterologyandhepatology.net/index.php/archives/july-2015/defining-severity-in-inflammatory-bowel-disease
Sign Up for Email Updates. For Email Newsletters you can trust. July 6, 2015. Defining Severity in Inflammatory Bowel Disease. Laurent Peyrin-Biroulet, MD, PhD. Head, IBD Unit. Why is it important to define severity in inflammatory bowel disease? What guidelines have clinicians been using to grade the severity of the disease? Why are these scores problematic? What other parameters are important to consider when evaluating disease severity? Have such definitions been proposed in the past? In December 2014...
